NO20013146L - Middel for behandling av synscellefunksjonsforstyrrelse - Google Patents

Middel for behandling av synscellefunksjonsforstyrrelse

Info

Publication number
NO20013146L
NO20013146L NO20013146A NO20013146A NO20013146L NO 20013146 L NO20013146 L NO 20013146L NO 20013146 A NO20013146 A NO 20013146A NO 20013146 A NO20013146 A NO 20013146A NO 20013146 L NO20013146 L NO 20013146L
Authority
NO
Norway
Prior art keywords
treatment
cell dysfunction
visual cell
visual
dysfunction
Prior art date
Application number
NO20013146A
Other languages
English (en)
Other versions
NO20013146D0 (no
Inventor
Ryuji Ueno
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO20013146D0 publication Critical patent/NO20013146D0/no
Publication of NO20013146L publication Critical patent/NO20013146L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20013146A 1998-12-24 2001-06-22 Middel for behandling av synscellefunksjonsforstyrrelse NO20013146L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11393998P 1998-12-24 1998-12-24
PCT/JP1999/007161 WO2000038703A1 (en) 1998-12-24 1999-12-20 Agent for treating visual cell function disorder

Publications (2)

Publication Number Publication Date
NO20013146D0 NO20013146D0 (no) 2001-06-22
NO20013146L true NO20013146L (no) 2001-08-20

Family

ID=22352417

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013146A NO20013146L (no) 1998-12-24 2001-06-22 Middel for behandling av synscellefunksjonsforstyrrelse

Country Status (13)

Country Link
EP (1) EP1140134A1 (no)
JP (1) JP2002542150A (no)
KR (1) KR20010099928A (no)
CN (1) CN1224420C (no)
AR (1) AR022017A1 (no)
AU (1) AU781049B2 (no)
BR (1) BR9917113A (no)
CA (1) CA2356382A1 (no)
MX (1) MXPA01006449A (no)
NO (1) NO20013146L (no)
NZ (1) NZ513111A (no)
TW (1) TW546145B (no)
WO (1) WO2000038703A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
WO2003061519A2 (en) 2002-01-18 2003-07-31 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
US8163726B2 (en) * 2002-09-18 2012-04-24 University Of Pennsylvania Method of inhibiting choroidal neovascularization
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
CA2539324A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
JP4974903B2 (ja) 2005-02-09 2012-07-11 参天製薬株式会社 疾患または状態を処置するための液体処方物
WO2007019427A2 (en) * 2005-08-08 2007-02-15 Massachusetts Eye & Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
PL2001466T3 (pl) 2006-03-23 2016-06-30 Santen Pharmaceutical Co Ltd Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
JP7431451B2 (ja) * 2018-10-15 2024-02-15 国立大学法人大阪大学 網膜および／または光受容に関連する症状の改善または予防用医薬ならびに網膜および／または光受容に関連する症状を改善または予防する物質のスクリーニング方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69124380T2 (de) * 1990-08-23 1997-08-14 Univ New York Verfahren und zusammensetzungen für die behandlung durch t-zellen vermittelter krankheiten
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5597809A (en) * 1994-06-23 1997-01-28 Massachusetts Eye & Ear Infirmary Treatment of optic neuritis
EP0994709A4 (en) * 1997-06-30 2006-02-01 Allergan Inc CALCIUM BLOCKER FOR THE TREATMENT OF PROLIFERATIVE VITREORETINOPATHY
CZ287497B6 (cs) * 1997-12-30 2000-12-13 Galena, A. S. Topické oční přípravky s imunosupresivními látkami
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders

Also Published As

Publication number Publication date
AU781049B2 (en) 2005-05-05
WO2000038703A1 (en) 2000-07-06
EP1140134A1 (en) 2001-10-10
NZ513111A (en) 2003-10-31
JP2002542150A (ja) 2002-12-10
CA2356382A1 (en) 2000-07-06
CN1224420C (zh) 2005-10-26
AR022017A1 (es) 2002-09-04
NO20013146D0 (no) 2001-06-22
MXPA01006449A (es) 2002-04-24
BR9917113A (pt) 2001-10-23
TW546145B (en) 2003-08-11
CN1352565A (zh) 2002-06-05
KR20010099928A (ko) 2001-11-09
AU1690600A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
DE60020327D1 (de) Wasserbehandlungsvorrichtung
NO20012160D0 (no) Anordning for behandling av makulös degenerering
EE200200710A (et) Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks
DE69828821D1 (de) Wasserbehandlungsverfahren
NO952749L (no) Middel for vannbehandling
DK0965566T3 (da) Fremgangsmåde til behandling af organisk spildevand
NO20010456D0 (no) Triazolopyridiner for behandling av trombose-problemer
NO20013146D0 (no) Middel for behandling av synscellefunksjonsforstyrrelser
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
AU4774599A (en) Process for the treatment of waste water
NO20013596L (no) Slambehandling
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
DK1054868T3 (da) Substituerede pyridinoarylpiperaziner egnede til behandling af prostatahyperplasi
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
NO20011892D0 (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
FI982378A0 (fi) Järjestely kohteen tutkimiseen
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
AU3843600A (en) Bath equipped with water vibrator and therapeutic method using the same
GB2332849B (en) Apparatus for the treatment of soil
DE50015962D1 (de) System zur Aufbereitung von Trinkwasser
ZA993450B (en) Decolourization of water.
NO996166L (no) FremgangsmÕte for behandling av avluter
ZA994585B (en) Treatment of water.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application